U.S. Markets closed

GlaxoSmithKline ADR’s Performance and Revenues in Q3 2018

Mike Benson
GlaxoSmithKline ADR’s Performance and Revenues in Q3 2018

GlaxoSmithKline (GSK) segregates its business portfolio into three business segments—Pharmaceuticals, Vaccines, and Consumer Healthcare. As a British multinational company, GlaxoSmithKline reports its revenues in pounds sterling. The chart below compares GlaxoSmithKline’s EPS and revenues since the first quarter of 2017, as well as its estimates for the third quarter.